Evidence map›Paper›PMID 33922330›Full record

ReviewMolecules (Basel, Switzerland)2021

Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.

Paul Cumming, Milan Scheidegger, Dario Dornbierer, Mikael Palner, Boris B Quednow, Chantal Martin-Soelch

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paul CummingDepartment of Nuclear Medicine, Bern University Hospital, CH-3010 Bern, Switzerland.ORCID 0000-0002-0257-9621
Milan ScheideggerDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital of the University of Zurich, CH-8032 Zurich, Switzerland.ORCID 0000-0003-1313-2208
Dario DornbiererDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital of the University of Zurich, CH-8032 Zurich, Switzerland.
Mikael PalnerOdense Department of Clinical Research, University of Southern Denmark, DK-5000 Odense, Denmark.ORCID 0000-0001-6014-2084
Boris B QuednowDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital of the University of Zurich, CH-8032 Zurich, Switzerland.
Chantal Martin-SoelchDepartment of Psychology, University of Fribourg, CH-1700 Fribourg, Switzerland.ORCID 0000-0003-3859-9023

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hallucinogens are a loosely defined group of compounds including LSD,

Indexed as

Molecular ImagingAnimalsBiomarkersCarrier ProteinsCerebrovascular CirculationClinical Studies as TopicDrug Evaluation, PreclinicalDrug MonitoringEnergy MetabolismHallucinogensHumansImage Processing, Computer-AssistedMolecular StructurePositron-Emission TomographyProtein BindingTomography, Emission-Computed, Single-PhotonBiomarkersCarrier ProteinsHallucinogenshallucinogensmolecular imagingPETserotonin receptorsSPECT

Identifiers

PMID33922330
PMCPMC8122807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.